TScan Therapeutics, Inc. (28)
Browse by Contract Category
Contracts
-
Description of the Registrants securities registered pursuant to Section 12 of the Securities and Exchange Act of 1934, as amended
(Filed With SEC on March 9, 2022)
-
Lease, by and between TScan Therapeutics, Inc. and BXP Waltham Woods LLC, dated November 29, 2021
(Filed With SEC on December 2, 2021)
-
Employment Agreement, dated July 28, 2021, by and between the Registrant and Zoran Zdraveski
(Filed With SEC on November 10, 2021)
-
2021 Employee Stock Purchase Plan
(Filed With SEC on April 30, 2021)
-
Services Agreement by and between Christoph Westphal and the Registrant, dated October 9, 2018
(Filed With SEC on April 23, 2021)
-
Non-Exclusive License Agreement by and between the Registrant and Provincial Health Services Authority, dated as of October 15, 2020
(Filed With SEC on April 23, 2021)
-
Employment Agreement, dated May 4, 2021, by and between the Registrant and Brian Silver
(Filed With SEC on May 5, 2021)
-
2021 Equity Incentive Plan and form of agreements thereunder
(Filed With SEC on May 5, 2021)
-
Form of Underwriting Agreement
(Filed With SEC on April 30, 2021)
-
Employment Agreement, dated April 23, 2021, by and between the Registrant and David Southwell
(Filed With SEC on April 23, 2021)
-
Form of Management Cash Incentive Plan
(Filed With SEC on April 23, 2021)
-
Employment Letter Agreement, dated April 23, 2021, by and between the Registrant and William Desmarais
(Filed With SEC on April 23, 2021)
-
Separation Agreement, dated January 26, 2021, by and between the Registrant and Henry Rath
(Filed With SEC on April 23, 2021)
-
Employment Letter Agreement, dated April 8, 2019, by and between the Registrant and Henry Rath
(Filed With SEC on April 23, 2021)
-
Employment Letter Agreement, dated April 23, 2021, by and between the Registrant and Gavin MacBeath, Ph.D
(Filed With SEC on April 23, 2021)
-
Fourth Amended and Restated Investors Rights Agreement, dated January 15, 2021, by and among the Registrant and the other parties thereto
(Filed With SEC on April 23, 2021)
-
Registration Rights Agreement made as of January 15, 2021 by and between the Registrant and the other parties thereto
(Filed With SEC on April 23, 2021)
-
Amended and Restated Royalty Agreement, dated as of June 12, 2018
(Filed With SEC on April 23, 2021)
-
Collaboration and License Agreement by and between the Registrant and Novartis Institutes for Biomedical Research, dated as of March 27, 2020
(Filed With SEC on April 23, 2021)
-
Option & Exclusive License Agreement by and between the Registrant and QIAGEN Sciences LLC, dated as of November 5, 2020
(Filed With SEC on April 23, 2021)
-
Lease by and between PPF OFF 828-830 Winter Street LLC and the Registrant, dated August 13, 2019
(Filed With SEC on April 23, 2021)
-
Amended and Restated Exclusive Patent License Agreement by and between the Registrant and The Brigham and Womens Hospital, Inc. dated April 20, 2021
(Filed With SEC on April 23, 2021)
-
2021 Employee Stock Purchase Plan
(Filed With SEC on April 23, 2021)
-
2021 Equity Incentive Plan and form of agreements thereunder
(Filed With SEC on April 23, 2021)
-
2018 Stock Plan, as amended, and forms of agreements thereunder
(Filed With SEC on April 23, 2021)
-
Form of Indemnification Agreement between the Registrant and each of its directors and executive officers
(Filed With SEC on April 23, 2021)
-
Amended and Restated Nominating Agreement, dated April 22, 2021, by and among the Registrant, Baker Brothers Life Sciences, L.P. and 667, L.P
(Filed With SEC on April 23, 2021)
-
Amendment No. 1 to Services Agreement Services Agreement by and between Christoph Westphal and the Registrant, dated June 24, 2019
(Filed With SEC on April 23, 2021)